Alessandro Digaetano Photographer

Show Navigation

Image 1 of 1

17 adsingapore_04_000504.jpg

Add to Lightbox Download
The Novartis Institute for Tropical Diseases (NITD) opening in Singapore's new Biopolis research facility. The Institute is focused on advanced biomedical research for neglected diseases, initially dengue fever and drug resistant tuberculosis (TB). The incidence of both these diseases is accelerating rapidly, particularly in the developing world. Today, more than one-third of the world's population is infected with TB and more than two million people die each year. In addition, 2.5 billion people worldwide are at risk from dengue fever. ..Novartis AG (NYSE: NVS) is a world leader in pharmaceuticals and consumer health. In 2003, the Group's businesses achieved sales of USD 24.9 billion and a net income of USD 5.0 billion. The Group invested approximately USD 3.8 billion in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ about 78 500 people and operate in over 140 countries around the world...The NITD is located in the 2 million square feet Biopolis research complex, an integrated biomedical research hub located in Singapore. Opened in October 2003, Biopolis boasts state-of-the-art scientific facilities, including nuclear magnetic resonance and DNA sequencing and hosting all of the biomedical research bodies, namely the Institute of Molecular and Cell Biology (IMCB), the Genome Institute of Singapore (GIS), the Bioprocessing Technology Institute (BTI), the Bioinformatics Institute (BII) and the Institute for Bioengineering and Nanotechnology (IBN) of the Agency for Science, Technology and Research (A*STAR).....The laboratories.
Copyright
Alessandro Digaetano
Image Size
3008x2000 / 1.7MB
Contained in galleries
The Novartis Institute for Tropical Diseases (NITD) opening in Singapore's new Biopolis research facility. The Institute is focused on advanced biomedical research for neglected diseases, initially dengue fever and drug resistant tuberculosis (TB). The incidence of both these diseases is accelerating rapidly, particularly in the developing world. Today, more than one-third of the world's population is infected with TB and more than two million people die each year. In addition, 2.5 billion people worldwide are at risk from dengue fever. ..Novartis AG (NYSE: NVS) is a world leader in pharmaceuticals and consumer health. In 2003, the Group's businesses achieved sales of USD 24.9 billion and a net income of USD 5.0 billion. The Group invested approximately USD 3.8 billion in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ about 78 500 people and operate in over 140 countries around the world...The NITD is located in the 2 million square feet Biopolis research complex, an integrated biomedical research hub located in Singapore. Opened in October 2003, Biopolis boasts state-of-the-art scientific facilities, including nuclear magnetic resonance and DNA sequencing and hosting all of the biomedical research bodies, namely the Institute of Molecular and Cell Biology (IMCB), the Genome Institute of Singapore (GIS), the Bioprocessing Technology Institute (BTI), the Bioinformatics Institute (BII) and the Institute for Bioengineering and Nanotechnology (IBN) of the Agency for Science, Technology and Research (A*STAR).....The laboratories.